- Report
- October 2024
- 189 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 182 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 192 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 186 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 197 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- January 2024
- 150 Pages
Global
From €5660EUR$5,950USD£4,764GBP
- Report
- October 2024
- 187 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 183 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- August 2024
- 132 Pages
Global
From €2844EUR$2,990USD£2,394GBP
- Report
- August 2024
- 175 Pages
Global
From €4756EUR$5,000USD£4,004GBP
- Report
- February 2024
- 175 Pages
Global
From €4756EUR$5,000USD£4,004GBP
- Report
- February 2024
- 175 Pages
Global
From €4756EUR$5,000USD£4,004GBP
- Report
- January 2024
- 200 Pages
Global
From €4756EUR$5,000USD£4,004GBP
- Report
- November 2024
- 194 Pages
Global
From €4709EUR$4,950USD£3,964GBP
- Report
- November 2024
- 193 Pages
Global
From €4709EUR$4,950USD£3,964GBP
- Report
- April 2024
- 136 Pages
Global
From €3709EUR$3,899USD£3,122GBP
- Report
- July 2024
Global
From €4613EUR$4,850USD£3,884GBP
- Report
- January 2024
- 150 Pages
Global
From €4613EUR$4,850USD£3,884GBP
- Report
- November 2023
- 154 Pages
Global
From €2378EUR$2,500USD£2,002GBP
- Report
- April 2024
- 115 Pages
Global
From €4280EUR$4,500USD£3,603GBP
The Asthma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat asthma. Asthma is a chronic respiratory condition that affects the airways, causing difficulty breathing, coughing, and wheezing. Asthma drugs are designed to reduce inflammation in the airways, making it easier for patients to breathe. These drugs can be taken orally, inhaled, or injected, depending on the severity of the condition. Common asthma drugs include corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the Asthma Drugs market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. These companies are involved in the research, development, and marketing of asthma drugs, as well as the production of generic versions of existing drugs. They also provide support services to patients, such as educational materials and access to specialists. Show Less Read more